Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Apple Is Giving Retail Investors More Reasons to Take a Bite

By Chris Markoch, InvestorPlace Contributor

The AAPL stock split shows timing is everything. Investors who were snatching up shares of the tech giant have even more reasons to buy.

When It Comes to Virgin Galactic Stock, There Is Absolutely No Rush to Jump In

By Chris Markoch, InvestorPlace Contributor

SPCE stock comes with a compelling story and a ton of risk. Bullish investors say to get on board now, but caution may be the better play.

Wait For Confirmation Before Signing Off on Docusign Stock

By Chris Markoch, InvestorPlace Contributor

Docusign stock is unquestionably a pandemic winner. But it may be time for investors to take some profits and let the stock cool off.

Ford Stock Looks Like a Tossup

By Chris Markoch, InvestorPlace Contributor

After seeing its stock bounce up over 70% from its low in March, Ford needs to successfully launch new vehicles to get F stock moving higher.

There Are Still 1.6 Million Reasons You’re Wrong About Luckin Stock

By Chris Markoch, InvestorPlace Contributor

Despite its ongoing legal issues, Luckin stock still gets interest from speculative investors. But a flawed business model begs the question why?

Buy Alibaba Stock While It’s Still at a Good Valuation

By Chris Markoch, InvestorPlace Contributor

Alibaba stock is at an all-time high after a stellar earnings report. But if investors want to wait for the dip, they may be waiting a while.

3 Reasons You Should Still Keep an Eye on Inovio Pharmaceuticals

By Chris Markoch, InvestorPlace Contributor

INO stock is dropping on news that its Covid-19 vaccine candidate is falling behind more established candidates. But science says there may still be a chance.

5 Airline Stocks Set to Survive the Pandemic

By Chris Markoch, InvestorPlace Contributor

The bar for airline stocks has been lowered, and now survival is the name of the game. Here are five airlines that will make it through.

XpresSpa Still Presents More Questions Than Answers

By Chris Markoch, InvestorPlace Contributor

XSPA stock is having a terrific year. Bullish investors believe it can turn into a viable resource for Covid-19 testing. That's a questionable assumption.

Workhorse Group Has Everything But Sales

By Chris Markoch, InvestorPlace Contributor

For investors considering jumping on WKHS stock, the formula is simple. Turn the good intentions of its customers into sales.

Load More